Immediate ART in Subjects with Opportunistic Diseases

NAActive, not recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
HIV/AIDSANTIRETROVIRAL TREATMENT
Interventions
OTHER

iART

After group assignment, ART will be started within the first 48 hours after admission to the hospital. ART regimen will be decided according to each subject´s the clinical characteristics

OTHER

cART

After group assignment, ART is started at the discretion of the attending physician. ART regimen will be decided according to each subject´s the clinical characteristics

Trial Locations (1)

14080

Centro de Investigacion en Enfermedades Infecciosas, México

All Listed Sponsors
lead

Gustavo Reyes-Teran

OTHER_GOV

NCT03825523 - Immediate ART in Subjects with Opportunistic Diseases | Biotech Hunter | Biotech Hunter